Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 26, 2019
Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot studyLukasz Koltowski, Mariusz Tomaniak, Dorota Ochijewicz, et al.
Postepy W Kardiologii Interwencyjnej = Advances in Interventional Cardiology|October 9, 2019
Quantitative flow ratio and fractional flow reserve mismatch - clinical and biochemical predictors of measurement discrepancyMartyna Zaleska, Lukasz Koltowski, Jakub Maksym, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 22, 2018
Quantitative flow ratio derived from diagnostic coronary angiography in assessment of patients with intermediate coronary stenosis: a wire-free fractional flow reserve studyŁukasz Kołtowski, Martyna Zaleska, Jakub Maksym, et al.
Polish Archives of Internal Medicine|March 18, 2018
District versus academic hospitals: differences in the clinical characteristics of patients with atrial fibrillation without valvular heart disease treated with oral anticoagulantsJanusz Bednarski, Paweł Balsam, Agata Tymińska, et al.
The American Journal of Cardiology|July 28, 2021
Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular ScaffoldLukasz Koltowski, Mariusz Tomaniak, Dorota Ochijewicz, et al.
Journal of Clinical Medicine|June 2, 2021
OCT-Derived Plaque Morphology and FFR-Determined Hemodynamic Relevance in Intermediate Coronary StenosesMariusz Tomaniak, Dorota Ochijewicz, Łukasz Kołtowski, et al.
Medicine|November 9, 2018
Clinical characteristics and thromboembolic risk of atrial fibrillation patients with and without congestive heart failure. Results from the CRATF studyPaweł Balsam, Monika Gawałko, Michał Peller, et al.
Cardiology Journal|November 9, 2018
Randomized controlled clinical trials versus real-life atrial fibrillation patients treated with oral anticoagulants. Do we treat the same patients?Paweł Balsam, Agata Tymińska, Krzysztof Ozierański, et al.
Kardiologia Polska|January 20, 2018
Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT studyPaweł Balsam, Krzysztof Ozierański, Agata Tymińska, et al.
Pageof 2